 | • レポートコード：QYR9ST04169 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、緑内障治療薬の世界市場について調査・分析し、緑内障治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（プロスタグランジン類似体、ベータ遮断薬、アルファアゴニスト、炭酸脱水酵素阻害薬）、用途別（眼科クリニック、病院、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の緑内障治療薬市場動向 ・主要企業別マーケットシェア ・緑内障治療薬の種類別市場規模2014-2019 （プロスタグランジン類似体、ベータ遮断薬、アルファアゴニスト、炭酸脱水酵素阻害薬） ・緑内障治療薬の用途別市場規模2014-2019 （眼科クリニック、病院、外来手術センター） ・緑内障治療薬の北米市場：主要企業・種類別/用途別市場規模 ・緑内障治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・緑内障治療薬の中国市場：主要企業・種類別/用途別市場規模 ・緑内障治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・緑内障治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・緑内障治療薬のインド市場：主要企業・種類別/用途別市場規模 ・緑内障治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Allergan、Pfizer、Novartis、Merck） ・緑内障治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Glaucoma is chronic, degenerative disorder that damages the eye’s optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics globally.The change in the lifestyle of people has resulted in the rise in the prevalence of glaucoma globally. Increasing prevalence of glaucoma is the primary factor driving the growth of glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. Rising geriatric population thought the globe is also responsible for the robust growth of glaucoma therapeutics market over the forecast period. Increasing preference of physician towards the laser surgery for the treatment of glaucoma will propel the growth of glaucoma therapeutics market over the forecast period. Less awareness among the people about the glaucoma treatment will deter the growth of glaucoma therapeutics market to some extent. Moreover, lack of availability of skilled professional for laser surgery in under developing economies will also hamper the growth of glaucoma therapeutics market.
The consumption of glaucoma drugs in the Americas is increasing due to the rising incidence of glaucoma in countries such as the US. Owing to its heavy investments in the healthcare sector, the US the major revenue contributor to the glaucoma therapeutics market in this region. With the presence of pharmaceutical giants and huge investments in the pharmaceutical industry, the need for glaucoma therapeutics will increase in the region during the predicted period.
In 2018, the global Glaucoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glaucoma Therapeutics development in United States, Europe and China.
The key players covered in this study
Allergan
Pfizer
Novartis
Merck
…
Market segment by Type, the product can be split into
Prostaglandin Analogs
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors
Market segment by Application, split into
Ophthalmic Clinic
Hospitals
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Glaucoma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Glaucoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glaucoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Prostaglandin Analogs
1.4.3 Beta Blockers
1.4.4 Alpha Agonists
1.4.5 Carbonic Anhydrase Inhibitors
1.5 Market by Application
1.5.1 Global Glaucoma Therapeutics Market Share by Application (2014-2025)
1.5.2 Ophthalmic Clinic
1.5.3 Hospitals
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Glaucoma Therapeutics Market Size
2.2 Glaucoma Therapeutics Growth Trends by Regions
2.2.1 Glaucoma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Glaucoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Glaucoma Therapeutics Market Size by Manufacturers
3.1.1 Global Glaucoma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Glaucoma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Glaucoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Glaucoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Glaucoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Glaucoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Glaucoma Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Glaucoma Therapeutics Market Size (2014-2019)
5.2 Glaucoma Therapeutics Key Players in United States
5.3 United States Glaucoma Therapeutics Market Size by Type
5.4 United States Glaucoma Therapeutics Market Size by Application
6 Europe
6.1 Europe Glaucoma Therapeutics Market Size (2014-2019)
6.2 Glaucoma Therapeutics Key Players in Europe
6.3 Europe Glaucoma Therapeutics Market Size by Type
6.4 Europe Glaucoma Therapeutics Market Size by Application
7 China
7.1 China Glaucoma Therapeutics Market Size (2014-2019)
7.2 Glaucoma Therapeutics Key Players in China
7.3 China Glaucoma Therapeutics Market Size by Type
7.4 China Glaucoma Therapeutics Market Size by Application
8 Japan
8.1 Japan Glaucoma Therapeutics Market Size (2014-2019)
8.2 Glaucoma Therapeutics Key Players in Japan
8.3 Japan Glaucoma Therapeutics Market Size by Type
8.4 Japan Glaucoma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Glaucoma Therapeutics Market Size (2014-2019)
9.2 Glaucoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Glaucoma Therapeutics Market Size by Type
9.4 Southeast Asia Glaucoma Therapeutics Market Size by Application
10 India
10.1 India Glaucoma Therapeutics Market Size (2014-2019)
10.2 Glaucoma Therapeutics Key Players in India
10.3 India Glaucoma Therapeutics Market Size by Type
10.4 India Glaucoma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Glaucoma Therapeutics Market Size (2014-2019)
11.2 Glaucoma Therapeutics Key Players in Central & South America
11.3 Central & South America Glaucoma Therapeutics Market Size by Type
11.4 Central & South America Glaucoma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glaucoma Therapeutics Introduction
12.1.4 Allergan Revenue in Glaucoma Therapeutics Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glaucoma Therapeutics Introduction
12.2.4 Pfizer Revenue in Glaucoma Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glaucoma Therapeutics Introduction
12.3.4 Novartis Revenue in Glaucoma Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glaucoma Therapeutics Introduction
12.4.4 Merck Revenue in Glaucoma Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Glaucoma Therapeutics Key Market Segments
Table Key Players Glaucoma Therapeutics Covered
Table Global Glaucoma Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Glaucoma Therapeutics Market Size Market Share by Type 2014-2025
Figure Prostaglandin Analogs Figures
Table Key Players of Prostaglandin Analogs
Figure Beta Blockers Figures
Table Key Players of Beta Blockers
Figure Alpha Agonists Figures
Table Key Players of Alpha Agonists
Figure Carbonic Anhydrase Inhibitors Figures
Table Key Players of Carbonic Anhydrase Inhibitors
Table Global Glaucoma Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Ophthalmic Clinic Case Studies
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Glaucoma Therapeutics Report Years Considered
Table Global Glaucoma Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Glaucoma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Glaucoma Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Glaucoma Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Glaucoma Therapeutics Market Share by Regions 2014-2019
Figure Global Glaucoma Therapeutics Market Share by Regions 2014-2019
Figure Global Glaucoma Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Glaucoma Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Glaucoma Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Glaucoma Therapeutics Market Share by Manufacturers in 2018
Table Global Glaucoma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Glaucoma Therapeutics Product/Solution/Service
Table Date of Enter into Glaucoma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Glaucoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Glaucoma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Glaucoma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Glaucoma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Glaucoma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Glaucoma Therapeutics Revenue Market Share by Application in 2018
Figure United States Glaucoma Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Glaucoma Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Glaucoma Therapeutics Market Share (2018-2019)
Table United States Glaucoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Glaucoma Therapeutics Market Share by Type (2014-2019)
Table United States Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Glaucoma Therapeutics Market Share by Application (2014-2019)
Figure Europe Glaucoma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Glaucoma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Glaucoma Therapeutics Market Share (2018-2019)
Table Europe Glaucoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Glaucoma Therapeutics Market Share by Type (2014-2019)
Table Europe Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Glaucoma Therapeutics Market Share by Application (2014-2019)
Figure China Glaucoma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Glaucoma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Glaucoma Therapeutics Market Share (2018-2019)
Table China Glaucoma Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Glaucoma Therapeutics Market Share by Type (2014-2019)
Table China Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Glaucoma Therapeutics Market Share by Application (2014-2019)
Figure Japan Glaucoma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Glaucoma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Glaucoma Therapeutics Market Share (2018-2019)
Table Japan Glaucoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Glaucoma Therapeutics Market Share by Type (2014-2019)
Table Japan Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Glaucoma Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Glaucoma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Glaucoma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Glaucoma Therapeutics Market Share (2018-2019)
Table Southeast Asia Glaucoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Glaucoma Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Glaucoma Therapeutics Market Share by Application (2014-2019)
Figure India Glaucoma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Glaucoma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Glaucoma Therapeutics Market Share (2018-2019)
Table India Glaucoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Glaucoma Therapeutics Market Share by Type (2014-2019)
Table India Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Glaucoma Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Glaucoma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Glaucoma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Glaucoma Therapeutics Market Share (2018-2019)
Table Central & South America Glaucoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Glaucoma Therapeutics Market Share by Type (2014-2019)
Table Central & South America Glaucoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Glaucoma Therapeutics Market Share by Application (2014-2019)
Table Allergan Company Details
Table Allergan Revenue in Glaucoma Therapeutics Business (2014-2019) (Million US$)
Figure Allergan Revenue Growth Rate in Glaucoma Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Glaucoma Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Glaucoma Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Glaucoma Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Glaucoma Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Glaucoma Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Glaucoma Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Global Glaucoma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Glaucoma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Glaucoma Therapeutics Market Size Share by Regions in 2025
Figure United States Glaucoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Glaucoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Glaucoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Glaucoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Glaucoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Glaucoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Glaucoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Glaucoma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Glaucoma Therapeutics Market Size by Product (2019-2025)
Figure Global Glaucoma Therapeutics Market Size by Product in 2025
Table Global Glaucoma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Glaucoma Therapeutics Market Size by Application (2019-2025)
Figure Global Glaucoma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の緑内障点眼薬市場：専門的調査 Eye drops used in managing glaucoma decrease eye pressure by helping the eye’s fluid to drain better andor decreasing the amount of fluid made by the eye. The global Glaucoma Eye Drops market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of …- 世界の緑内障レーザー装置市場：専門的調査 Glaucoma laser system is changing the future vision of glaucoma patients with selective laser trabeculoplasty. The global Glaucoma Laser Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuse…
- 肥大型心筋症治療薬の世界市場：市場規模・現状・予測 HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …
- 世界の緑内障治療装置市場：専門的調査 Glaucoma is a condition that causes damage to your eye's optic nerve and gets worse over time. Glaucoma treatment device is also possible to be divided into glaucoma laser devices and glaucoma drainage devices. The global Glaucoma Treatment Devices market was valued at xx million US$ in 2018 and wil…
- 世界の緑内障治療装置市場：専門的調査 Glaucoma is a condition that causes damage to your eye's optic nerve and gets worse over time. Glaucoma treatment device is also possible to be divided into glaucoma laser devices and glaucoma drainage devices. The global Glaucoma Treatment Devices market was valued at xx million US$ in 2018 and wil…